Skip to main content

CORRECTION article

Front. Genet., 05 December 2022
Sec. Neurogenomics
Volume 13 - 2022 | https://doi.org/10.3389/fgene.2022.1106086
This article is part of the Research Topic Evolution In Neurogenomics View all 6 articles

Corrigendum: m6A regulatory gene-mediated methylation modification in glioma survival prediction

This article is a correction to:

  1. m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction

    1. Read original article
Guiyun Zhang&#x;Guiyun Zhang1†Ping Zheng&#x;Ping Zheng2†Yisong LvYisong Lv3Zhonghua Shi Zhonghua Shi4*Fei Shi Fei Shi1*
  • 1Department of Neurovascular Intervention and Neurosurgery, School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
  • 2Department of Neurovascular Intervention, Clinical Center of Neuroscience, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • 3School of Continuing Education, Shanghai Jiao Tong University, Shanghai, China
  • 4Department of Neurosurgery, 904th Hospital of PLA, Wuxi, China

A Corrigendum on
m6A regulatory gene-mediated methylation modification in glioma survival prediction

by Zhang G, Zheng P, Lv Y, Shi Z and Shi F (2022). Front. Genet. 13:873764. doi: 10.3389/fgene.2022.873764

In the published article, there was an error in Affiliation 1. Instead of “Department of Neurovascular Intervention and Neurosurgery, School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China”, it should be “Department of Neurovascular Intervention, Clinical Center of Neuroscience, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: glioblastoma, low grade glioma, TCGA, M6A, immune infiltration

Citation: Zhang G, Zheng P, Lv Y, Shi Z and Shi F (2022) Corrigendum: m6A regulatory gene-mediated methylation modification in glioma survival prediction. Front. Genet. 13:1106086. doi: 10.3389/fgene.2022.1106086

Received: 23 November 2022; Accepted: 24 November 2022;
Published: 05 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhang, Zheng, Lv, Shi and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhonghua Shi, emhvbmdodWEzMzcyQHFxLmNvbQ==; Fei Shi, Y2hvYml0MzlAc2luYS5jb20=

†These authors have contributed equally to this work and share the first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.